GeneDx Holdings WGS
$45.46 −$3.78 (-7.68%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.35 +1.96%
Open$47.95
Prev close$49.24
Day range$45.16 – $49.10
Volume912.6K
Market cap$1.36B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$123.10M+5.4% YoY
Operating profit-$9.53M-225.5% YoY
Net profit-$12.33M-61.5% YoY
Diluted EPS-$0.41-51.9% YoY
Free cash flow-$15.82M-264.9% YoY
Operating cash flow-$10.60M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin68.7%
Operating margin-14.3%
Net margin-24.1%
Return on equity-41.4%
Return on assets-21.8%
Return on invested capital-25.7%
Current ratio4.16
Liabilities / assets53.5%
Cash & investments$170.12M
Total debt$209.56M
Net cash (debt)-$39.44M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $123.10M | $114.44M | $102.25M | $427.54M | $120.99M |
| Total Operating Revenue | $123.10M | $114.44M | $102.25M | $427.54M | $120.99M |
| Cost of Revenue | $37.04M | $36.20M | $34.04M | $129.37M | $36.72M |
| Gross Profit | $86.06M | $78.24M | $68.21M | $298.17M | $84.27M |
| Operating Expense | $95.59M | $93.48M | $94.40M | $311.25M | $99.43M |
| Selling and Admin Expenses | $77.06M | $72.73M | $74.59M | $239.22M | $77.06M |
| -General & Admin Expense | $77.06M | $72.73M | – | $150.82M | -$11.35M |
| Research & Development | $17.37M | $19.66M | $19.80M | $72.03M | $24.54M |
| Depreciation & Amortization & Depletion | $1.16M | $1.10M | – | – | – |
| -Depreciation & Amortization | $1.16M | $1.10M | – | – | – |
| Operating Profit | -$9.53M | -$15.24M | -$26.18M | -$13.08M | -$15.16M |
| Net Non-Operating Interest Income (Expense) | -$1.78M | -$1.19M | -$717,000.00 | -$2.54M | -$520,000.00 |
| Non-Operating Interest Expense | $1.78M | $1.19M | $717,000.00 | – | – |
| Other Income (Expense) | -$994,000.00 | -$1.83M | -$35.52M | -$5.52M | -$2.55M |
| Special Income (Charges) | -$900,000.00 | -$2.21M | -$37.85M | $0.00 | $927,000.00 |
| -Less:Restructuring and Mergern & Acquisition | $900,000.00 | $2.21M | – | – | – |
| -Less:Impairment of Capital Assets | $0.00 | $0.00 | – | – | – |
| Other Non-Operating Income (Expenses) | -$94,000.00 | $382,000.00 | -$206,000.00 | -$4.32M | -$2.27M |
| Pretax Profit | -$12.30M | -$18.26M | -$62.42M | -$21.14M | -$18.23M |
| Tax | $26,000.00 | -$518,000.00 | $897,000.00 | -$116,000.00 | -$564,000.00 |
| Net Profit | -$12.33M | -$17.74M | -$63.32M | -$21.02M | -$17.67M |
| Profit from Continuing Operations | -$12.33M | -$17.74M | -$63.32M | -$21.02M | -$17.67M |
| Net Income to Parent Company | -$12.33M | -$17.74M | -$63.32M | -$21.02M | -$17.67M |
| Net Income to Common Stockholders | -$12.33M | -$17.74M | -$63.32M | -$21.02M | -$17.67M |
| Basic EPS | -$0.41 | -$0.60 | -$2.16 | -$0.73 | -$0.61 |
| Diluted EPS | -$0.41 | -$0.60 | -$2.16 | -$0.73 | -$0.61 |
| Gain on Sale of Security | – | – | $2.54M | -$1.20M | $1.12M |
| -Less:Other Special Charges | – | – | $6.57M | – | – |
| -Less:Write Off | – | – | $31.29M | $0.00 | – |
| -Selling & Marketing Expense | – | – | – | $88.41M | $27.13M |
| Total Other Finance Costs | – | – | – | $2.54M | $520,000.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $526.48M | $481.49M | $506.30M | $523.71M | $523.71M |
| Total Current Assets | $296.90M | $246.36M | $270.63M | $268.29M | $268.29M |
| Cash and Cash Equivalents & Short-Term Investments | $170.12M | $132.55M | $170.69M | $171.28M | $171.28M |
| -Cash and Cash Equivalents | $96.14M | $60.32M | $93.92M | $105.00M | $105.00M |
| -Short Term Investments | $73.98M | $72.23M | $76.76M | $66.29M | $66.29M |
| Receivables | $92.13M | $83.61M | $76.93M | $74.37M | $74.37M |
| -Accounts Receivable | $92.13M | $83.61M | $76.93M | $74.37M | $74.37M |
| Prepaid Assets | $11.30M | $11.35M | $9.76M | $7.17M | $7.17M |
| Inventory | $21.70M | $17.82M | $12.24M | $13.95M | $13.95M |
| Other Current Assets | $1.64M | $1.04M | $1.01M | $1.51M | $1.51M |
| Total Non-Current Assets | $229.59M | $235.13M | $235.67M | $255.42M | $255.42M |
| Net PPE | $85.94M | $87.85M | $84.78M | $69.11M | $69.11M |
| -Gross PPE | $120.71M | $119.30M | $113.07M | $94.62M | $94.62M |
| -Accumulated Depreciation | -$34.78M | -$31.45M | -$28.29M | -$25.52M | -$25.52M |
| Goodwill and Other Intangible Assets | $139.37M | $142.99M | $146.61M | $182.00M | $182.00M |
| -Goodwill | $1.64M | $1.64M | $1.64M | $13.52M | $13.52M |
| -Other Intangible Assets | $137.73M | $141.35M | $144.97M | $168.48M | $168.48M |
| Other Non-Current Assets | $4.28M | $4.28M | $4.28M | $4.32M | $4.32M |
| Total Liabilities | $281.80M | $237.27M | $252.18M | $215.53M | $215.53M |
| Total Current Liabilities | $71.40M | $74.63M | $87.64M | $108.91M | $108.91M |
| Payables | $3.66M | $5.47M | $11.93M | $3.10M | $3.10M |
| -Accounts Payable | $3.32M | $5.15M | $11.17M | $2.46M | $2.46M |
| -Due to Related Parties Current | $339,000.00 | $320,000.00 | $758,000.00 | $643,000.00 | $643,000.00 |
| Current Accrued Expenses | $23.61M | $30.20M | $24.66M | $44.66M | $44.66M |
| Short-Term Debt and Capital Lease Obligation | $5.82M | $5.71M | $5.13M | $8.95M | $8.95M |
| -Current Capital Lease Obligation | $5.82M | $5.71M | $5.13M | $4.40M | $4.40M |
| Current Provisions | $5.50M | $6.74M | $10.74M | $10.53M | $10.53M |
| Other Current Liabilities | $11.55M | $9.55M | $14.11M | $11.27M | $11.27M |
| Total Non-Current Liabilities | $210.39M | $162.64M | $164.54M | $106.62M | $106.62M |
| Long Term Debt and Capital Lease Obligation | $209.56M | $161.69M | $163.06M | $104.22M | $104.22M |
| -Long Term Debt | $146.23M | $96.84M | $96.73M | $48.18M | $48.18M |
| -Long Term Capital Lease Obligation | $63.33M | $64.86M | $66.33M | $56.05M | $56.05M |
| Non-Current Deferred Liabilities | $760,000.00 | $873,000.00 | $1.40M | $757,000.00 | $757,000.00 |
| Other Non-Current Liabilities | $71,000.00 | $71,000.00 | $71,000.00 | $1.64M | $1.64M |
| Total Equity | $244.69M | $244.22M | $254.12M | $308.18M | $308.18M |
| Stockholders' Equity | $244.69M | $244.22M | $254.12M | $308.18M | $308.18M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.71B | $1.70B | $1.69B | $1.68B | $1.68B |
| Retained Earnings | -$1.47B | -$1.45B | -$1.44B | -$1.37B | -$1.37B |
| Gains/Losses Not Affecting Retained Earnings | -$111,000.00 | $342,000.00 | $683,000.00 | $936,000.00 | $936,000.00 |
| -Current Debt | – | – | – | $4.54M | $4.54M |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$10.60M | -$28.98M | -$32.41M | $33.28M | -$3.09M |
| Net cash flow from continuing operations | -$10.60M | -$28.98M | -$32.41M | $33.28M | -$3.09M |
| Net Income from Continuing Operations | -$12.33M | -$17.74M | -$63.32M | -$21.02M | -$17.67M |
| Gain/Loss from Continuing Operations | $0.00 | -$220,000.00 | $4.03M | – | – |
| Depreciation & Depletion & Amortization | $6.90M | $6.71M | $6.81M | $25.22M | $6.88M |
| Deferred Tax | $26,000.00 | -$518,000.00 | $897,000.00 | – | – |
| Other Non-Cash Items | $1.11M | -$921,000.00 | $2.06M | $12.38M | $286,000.00 |
| Change in Working Capital | -$14.55M | -$22.64M | -$23.16M | -$15.60M | $262,000.00 |
| -Change in Receivables | -$8.74M | -$6.68M | -$2.56M | -$36.23M | -$13.43M |
| -Change in Inventory | -$3.85M | -$5.66M | $1.69M | -$3.44M | -$3.36M |
| -Change in Payables and Accrued Expense | -$6.74M | $602,000.00 | -$13.17M | $12.10M | $6.92M |
| -Change In Other Working Capital | $4.78M | -$10.90M | -$9.13M | $11.97M | $10.14M |
| Net cash flow from investing | -$7.42M | -$5.63M | -$17.26M | -$61.52M | -$11.07M |
| Net Cash Flow from Continuing Investing Activities | -$7.42M | -$5.63M | -$17.26M | -$61.52M | -$11.07M |
| Net PPE Purchase and Sale | -$5.22M | -$10.11M | -$6.45M | -$19.02M | -$4.35M |
| Net Business Purchase and Sale | $0.00 | – | – | -$32.86M | $339,000.00 |
| Net Investment Purchase and Sale | -$2.19M | $4.48M | -$10.80M | -$9.64M | -$7.06M |
| Financing Cash Flow | $53.84M | $1.01M | $38.59M | $48.03M | $23.19M |
| Net Cash Flow from Continuing Financing Activities | $53.84M | $1.01M | $38.59M | $48.03M | $23.19M |
| Net Issuance Payments Of Debt | $48.84M | $96.21M | -$58.94M | -$3.66M | -$682,000.00 |
| Net Common Stock Issuance | $5.00M | -$95.21M | $97.47M | $46.70M | $19.87M |
| Proceeds from Stock Option Exercised | $0.00 | $0.00 | $58,000.00 | $4.98M | $4.00M |
| Ending Cash Balance | $97.13M | $61.31M | $94.92M | $105.99M | $105.99M |
| Net Change in Cash | $35.82M | -$33.61M | -$11.07M | $19.79M | $9.03M |
| Beginning Cash Balance | $61.31M | $94.92M | $105.99M | $86.20M | $96.96M |
| Free Cash Flow | -$15.82M | -$39.10M | -$38.86M | $14.26M | -$7.44M |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on WGS.
Sign in to join the discussion.